GENinCode (LON:GENI) Trading Down 1.6% – Here’s Why

GENinCode Plc (LON:GENIGet Free Report)’s stock price dropped 1.6% during mid-day trading on Wednesday . The stock traded as low as GBX 2.41 ($0.03) and last traded at GBX 2.41 ($0.03). Approximately 633,151 shares changed hands during trading, a decline of 6% from the average daily volume of 676,595 shares. The stock had previously closed at GBX 2.45 ($0.03).

GENinCode Price Performance

The company has a fifty day moving average price of GBX 3.02 and a two-hundred day moving average price of GBX 3.71. The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.28. The company has a market cap of £4.28 million, a price-to-earnings ratio of -0.70 and a beta of 0.66.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Further Reading

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.